Tissue Perfusion Pressure for Predicting Fluid Responsiveness in Patients With Shock
1 other identifier
observational
34
0 countries
N/A
Brief Summary
This prospective observational study aims to evaluate the ability of tissue perfusion pressure (TPP) to predict fluid responsiveness in critically ill patients with shock and tissue hypoperfusion. Eligible patients requiring fluid resuscitation will undergo a standardized fluid challenge test. Hemodynamic parameters, including cardiac output and TPP, will be recorded before and after fluid administration. Fluid responsiveness will be defined according to the change in cardiac output following fluid loading. The study will assess the correlation between changes in TPP and cardiac output and evaluate the diagnostic performance of TPP for predicting fluid responsiveness. The results may support the use of TPP as a practical and physiologically relevant parameter for individualized fluid management in patients with shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2026
CompletedFirst Posted
Study publicly available on registry
June 26, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
June 26, 2026
June 1, 2026
1.8 years
June 4, 2026
June 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Δ Cardiac output
Periprocedural
Δ Tissue perfusion pressure
Periprocedural
Study Arms (1)
all
Interventions
Eligibility Criteria
The study population will consist of critically ill adult patients with shock and tissue hypoperfusion admitted to the Intensive Care Unit of Zhongda Hospital, Southeast University. Patients requiring fluid resuscitation and invasive hemodynamic monitoring as part of routine clinical care will be screened for eligibility and consecutively enrolled in this prospective observational study.
You may qualify if:
- Age ≥18 years
- Admitted to the Intensive Care Unit (ICU)
- Diagnosed with shock and evidence of tissue hypoperfusion
- Judged by the treating physician to require fluid resuscitation
- Receiving invasive hemodynamic monitoring
- Written informed consent obtained from the patient or legally authorized representative
You may not qualify if:
- Pregnancy
- Immediate requirement for extracorporeal life support, including: VV-ECMO, VA-ECMO, Ventricular assist devices
- Expected survival less than 72 hours
- Absence of invasive arterial pressure monitoring or arterial waveform availability \<25%
- Any condition deemed unsuitable for study participation by the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jingyuan,Xulead
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Zhongda Hospital
Study Record Dates
First Submitted
June 4, 2026
First Posted
June 26, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
June 26, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share